Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.
Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.
复制标题
DOI：
10.1186/1476-4598-11-69
复制
发表时间：
2012-09-14
期刊：
影响因子：
37.3
通讯作者：
Pils D
中科院分区：
文献类型：
--
作者：
Aust S;Bachmayr-Heyda A;Pateisky P;Tong D;Darb-Esfahani S;Denkert C;Chekerov R;Sehouli J;Mahner S;Van Gorp T;Vergote I;Speiser P;Horvat R;Zeillinger R;Pils D
The role of the tumor necrosis factor receptor associated protein 1 (TRAP1) – supposed to be involved in protection of cells from apoptosis and oxidative stress – has just started to be investigated in ovarian cancer. TRAP1 has been shown to be estrogen up-regulated in estrogen receptor α (ERα) positive ovarian cancer cells. The clinical impact of TRAP1 is not clear so far and the significance of ERα expression as therapeutic and prognostic marker is still controversial. Therefore, we investigated the importance of TRAP1 together with ERα in regard to clinicopathological parameters, chemotherapy response, and survival. Expressions of TRAP1 and ERα were evaluated by immunohistochemical staining of tissue microarrays comprised of 208 ovarian cancer samples. TRAP1 was highly expressed in 55% and ERα was expressed in 52% of all cases. High TRAP1 expression correlated significantly with ERα (p < 0.001) but high TRAP1 expression was also found in 42% of ERα negative cases. High TRAP1 expression correlated significantly with favorable chemotherapy-response (HR = 0.48; 95%CI 0.24-0.96, p=0.037) and showed a significant impact on overall survival (OS) (HR = 0.65; 95%CI 0.43-0.99, p = 0.044). ERα expression was a favorable prognostic factor for OS in univariate and multivariate analyses. Interestingly, the combined pattern (ERα positive and/or TRAP1-high) revealed the strongest independent and significant positive influence on OS (HR = 0.41; 95%CI 0.27-0.64). Immunohistochemical evaluation of TRAP1 together with ERα provides significant prognostic information. TRAP1 alone is significantly associated with chemotherapy response and overall survival, rendering TRAP1 as interesting scientific and therapeutic target.
登录
查看更多内容
乳腺癌进展中的热休克蛋白 - 适合治疗的病例？
DOI：
10.3109/02656736.2010.490254
发表时间：
2010
期刊：
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
影响因子：
--
作者：
Calderwood SK
通讯作者：
Calderwood SK
影响因子：
2
作者：
Bretz, Frank;Maurer, W.;Posch, Martin
通讯作者：
Posch, Martin
影响因子：
9.7
作者：
Yamamoto, K;Okamoto, A;Ohtake, Y
通讯作者：
Ohtake, Y
DOI：
10.1080/10253890701314863
发表时间：
2007-11-01
影响因子：
2.3
作者：
Gesualdi, N. Montesano;Chirico, G.;Esposito, F.
通讯作者：
Esposito, F.
DOI：
10.1158/1055-9965.epi-08-1214
发表时间：
2009-05
期刊：
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子：
--
作者：
Hecht JL;Kotsopoulos J;Hankinson SE;Tworoger SS
通讯作者：
Tworoger SS